Bremer Bank National Association Abbott Laboratories Transaction History

Bremer Bank National Association

$526 Million
Q3 2024

A detailed history of Bremer Bank National Association transactions in Abbott Laboratories stock. As of the latest transaction made, Bremer Bank National Association holds 7,998 shares of ABT stock, worth $941,844. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,998

Previous 8,077 0.98%

Holding current value

$941,844

Previous $839,000 8.58%

% of portfolio

0.17%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$100.07 - $118.13 $7,905 - $9,332	-79 Reduced 0.98%	7,998 $911,000
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $95,794 - $106,930	-951 Reduced 10.53%	8,077 $839,000
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $378,610 - $418,158	-3,457 Reduced 27.69%	9,028 $1.03 Million
Q4 2023 Jan 11, 2024	SELL	$90.19 - $110.4 $34,091 - $41,731	-378 Reduced 2.94%	12,485 $1.37 Million
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $8,024 - $9,628	-84 Reduced 0.65%	12,863 $1.25 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $60,871 - $67,823	-604 Reduced 4.46%	12,947 $1.41 Million
Q1 2023 Apr 13, 2023	SELL	$96.86 - $114.01 $101,412 - $119,368	-1,047 Reduced 7.17%	13,551 $1.37 Million
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $145,441 - $170,625	1,530 Added 11.71%	14,598 $1.6 Million
Q3 2022 Oct 12, 2022	SELL	$96.76 - $112.03 $216,258 - $250,387	-2,235 Reduced 14.6%	13,068 $1.27 Million
Q2 2022 Jul 08, 2022	SELL	$102.07 - $123.37 $100,947 - $122,012	-989 Reduced 6.07%	15,303 $1.66 Million
Q1 2022 Apr 07, 2022	SELL	$114.02 - $139.04 $2.86 Million - $3.49 Million	-25,127 Reduced 60.67%	16,292 $1.93 Million
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $1.18 Million - $1.44 Million	-10,172 Reduced 19.72%	41,419 $5.83 Million
Q3 2021 Oct 05, 2021	SELL	$116.66 - $129.06 $157,024 - $173,714	-1,346 Reduced 2.54%	51,591 $6.09 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $70,879 - $83,435	-670 Reduced 1.25%	52,937 $6.14 Million
Q1 2021 Apr 07, 2021	BUY	$108.84 - $128.23 $60,297 - $71,039	554 Added 1.04%	53,607 $6.43 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $102,165 - $111,330	-973 Reduced 1.8%	53,053 $5.81 Million
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $380,306 - $461,853	-4,150 Reduced 7.13%	54,026 $5.88 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $59,265 - $75,852	-774 Reduced 1.31%	58,176 $5.32 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $73,122 - $106,925	1,164 Added 2.01%	58,950 $4.65 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $153,015 - $170,342	1,949 Added 3.49%	57,786 $5.02 Million
Q3 2019 Oct 03, 2019	SELL	$81.84 - $88.74 $839,187 - $909,939	-10,254 Reduced 15.51%	55,837 $4.67 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $31,338 - $36,550	430 Added 0.65%	66,091 $5.56 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $4.35 Million - $5.26 Million	65,661 New	65,661 $5.22 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.

Account

Bremer Bank National Association Abbott Laboratories Transaction History